Search

everythinglearnresearchcommunity

for

Search:↓

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Reference values for nine hormones were established to help diagnose PCOS.

Eating alfalfa sprouts every day can raise testosterone levels in middle-aged men, but broccoli sprouts don't have this effect.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Low prolactin in young women may increase heart and metabolism risks.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.